Paracrine regulation of cardiac myocytes in normal and septic heart

Journal of Critical Care

Volumn 13, Issue 1, 1998, Pages 39-47

  Corda, Stefano ^a   Mebazaa, Alexandre ^a   Tavernier, Benoît ^a   Ayed, Moncef Ben ^a   Payen, Didier ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRADYKININ; ENDOTHELIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN;

CELL TYPE; ENDOCARDIUM; ENDOTHELIUM; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; IMMUNOPATHOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 0031923218     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-9441(98)90028-4     Document Type: Review

References (83)

1. Furchgott R, Zawadski J: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 288:373-376, 1980
2. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993
3. Dusting G, MacDonald P: Prostacyclin and vascular function: Implications for hypertension and aterosclerosis. Pharmacol Ther 48:323-344, 1990
4. Rubanyi G, Polokoff M: Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46:325-415, 1994
5. Ramaciotti C, Sharkey A, McClellan G, et al: Endothelial cells regulate cardiac contractility. Proc Natl Acad Sci 89:4033-4036, 1992
6. Brutsaert DL, Andries LJ: The endocardial endothelium. Am J Physiol 263:H985-H1002, 1992
7. Shah AM: Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res 31:847-867, 1996
8. Mebazaa A, Mayoux E, Maeda K, et al: Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol 265:H1841-H1846, 1993
9. Shah AM, Mebazaa A, Wetzel RC, et al: A novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells. Circulation 89:2492-2497, 1994
10. 2+ independent nitric oxide synthase in the myocardium. Br J Pharmacol 105:575-580, 1992
11. Balligand JL, Ungureanu-Longrois D, Simmons WW, et al: Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1β and IFN-γ. Am J Physiol 268:H1293-H1303, 1995
12. Smith J, Radomski M, Schulz R, et al: Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase. Br J Pharmacol 108:1107-1110, 1993
13. Brutsaert DL, Meulemans AL, Sipido KR, et al: Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 62:358-366, 1988
14. Fort S, Lewis M, Shah A: The role of endocardial endothelium in the modulation of myocardial control in the isolated whole heart. Cardioscience 4:217-223, 1993
15. Shah AM, Andries LJ, Meulemans AL, et al: Endocardium modulates myocardial inotropic response to 5-hydroxitriptamine. Am J Physiol 257:H1790-H1797, 1989
16. Paulus WJ, Vantrimpont PJ, Shah AM: Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in man. Circulation 89:2070-2078, 1994
17. Ramaciotti C, McClellan G, Sharkey A, et al: Cardiac endothelial cells modulate contractility of the rat heart in response to oxygen tension and coronary flow. Circ Res 72:1044-1064, 1993
18. Shah AM, Mebazaa A, Yang ZK, et al: Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells: A potential mechanism for matching oxygen supply and demand? Circ Res 80:688-698, 1997
19. Smith J, Shah A, Lewis M: Factors released from the endocardium of the ferret and the pig modulate myocardial contraction. J Physiol (Lond) 439:1-14, 1991
20. Natan C, Xie Q: Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728, 1994
21. Balligand JL, Ungureanu-Longrois D, Simmons WW, et al: Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 296:27580-27588, 1994
22. Belhassen L, Kelly RA, Smith TW, et al: Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. J Clin Invest 97:1908-1915, 1996
23. Nava E, Noll G, Luscher T: Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91:2310-2313, 1995
24. Kelly RA, Balligand JL, Smith TW: Nitric oxide and cardiac function. Circ Res 79:363-380, 1996
25. Mebazaa A, Paqueron X, De Keulanaer G, et al: Myocardial depression during sepsis is not related to nitric oxide. Am J Respir Crit Care Med 153:A836, 1996 (abstr)
26. Shah AM, Lewis MJ, Henderson AH: Effects of 8-bromo-cyclic GMP on contraction and on inotropic response of ferret and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol 23:55-64, 1990
27. Paulus W, Vantrimpont PJ, Shah AM: Paracrine coronary endothelial control of left ventricular function in humans. Circulation 92:2119-2126, 1995
28. Pinsky DJ, Patton S, Mesaros S, et al: Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 81:372-379, 1997
29. Prendergast BD, Sagach VF, Shah AM: Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 96:1320-1329, 1997
30. Shah AM, Spurgeon H, Sollott SJ, et al: 8-bromo cyclic GMP reduces the myofilament response to calcium in intact cardiac myocytes. Circ Res 74:970-978, 1994
31. Pepper CB, Lang D, Lewis MJ, et al: Endothelial inhibition of myofilament calcium response in intact cardiac myocytes. Am J Physiol 269:H1538-H1544, 1995
32. Balligand JL, Kelly RA, Marsden PA, et al: Control of cardiac muscle function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 90:347-351, 1993
33. Wildhirt S, Dudeck R, Suzuki R, et al: Immunohystochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res 29:526-531, 1995
34. Nishida M, Springhorn J, Kelly RA, et al: Cell-cell signalling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture. J Clin Invest 91:1934-1941, 1993
35. Hirata Y, Fukuda Y, Yoshimi H, et al: Specific receptors for endothelin in cultured rat cardiocytes. Biochem Biophys Res Commun 160:1438-1444, 1989
36. Moody C, Dashwood M, Sykes R, et al: Functional and autoradiographic evidence of endothelin-1 receptors on human and rat cardiac myocytes: Comparison with single smooth muscle cells. Circ Res 67:764-769, 1990
37. Hilal Dandan R, Urasawa K, Brunton L: Endothelin inhibits adenylate cyclase and stimulates phosphoinositide hydrolisis in adult cardiac myocytes. J Biol Chem 267:10620-10624, 1992
38. Frelin C, Guedin D: Why are circulating concentrations of endothelin so low? Cardiovasc Res 28:1613-1622, 1994
39. Wagner O, Christ G, Wojta G, et al: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068, 1992
40. McClellan G, Weiberg A, Rose D, et al: Endothelial cell storage and release of endothelin as a cardioregulatory mechanism. Circ Res 70:787-803, 1994
41. McClellan G, Weisberg A, Winegrad S: Endothelin regulation of cardiac contractility in the absence of added endothelin. Am J Physiol 268:H1621-H1627, 1995
42. Mebazaa A, Martin L, Robotham J, et al: Right and left ventricular cultured endocardial endothelium produces prostacyclin and PGE2. J Mol Cell Cardiol 25:245-248, 1993
43. Mebazaa A, Wetzel RC, Cherian M, et al: Comparison between endothelial and great vessels endothelial cells: morphology, growth, and prostaglandin release. Am J Physiol 268:H250-H259, 1995
44. Schrör K, Hohfeld T: Inotropic effects of eicosanoids. Basic Res Cardiol 87:2-11, 1992
45. Claycombe K, Lee D, Miller H: Proportions of rat ANP-secreting cells that are cardiomyocytes and that synthesize the hormone. Am J Physiol 268:H265-H270, 1995
46. Fukuda Y, Hirata Y, Yoshimi H, et al: Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem Biophys Res Commun 155:167-172, 1988
47. Lew R, Baertschi A: Endothelium-dependent ANF secretion in vitro. Am J Physiol 263:H1701-H1707, 1992
48. Yamamoto K, Redfield M, Burnett JC: Natriuretic peptides and cardiac function. Lewis MJ, Shah AM (eds): Endothelial Modulation of Cardiac Function. Amsterdam, Hardwood Academic, pp 205-221, 1997
49. Anand-Srivastava M, Cantin M: Atrial natriuretic factor receptors are negatively coupled to adenylate cyclase in cultured atrial and ventricular cardiocytes. Biochem Biophys Res Commun 138:427-436, 1986
50. Paul M, Bachmann J, Ganten D: The tissue reninangiotensin system in cardiovascular disease. Trends in Cardiovascular Medicine 2:94-99, 1992
51. Linz W, Wiemer G, Gohlke P, et al: Contributions of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47:25-49, 1995
52. Ikeda U, Maeda Y, Kawahara Y, et al: Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation 92:2683-2689, 1995
53. Sadoshima J, Izumo S: Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of AT 1 receptor subtype. Circ Res 73:413-423, 1993
54. Ikenouchi H, Barry W, Bridge J, et al: Effects of angiotensin II on intracellular Ca2+ and pH in isolated beating rabbit hearts and myocytes loaded with the indicator indo-1. J Physiol 480:203-215, 1994
55. Grocott-Mason RM, Anning PB, Evans H, et al: Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267:1804-1813, 1994
56. Anning P, Grocott-Mason R, Lewis M, et al: Enhancement of left ventricular relaxation in the isolated heart by an angiotensin converting enzyme inhibitor. Circulation 92:2660-2665, 1995
57. Parker M, Natanson C, Suffredini R, et al: Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 113:227-242, 1990
58. Suffredini A, Fromm R, Parker M, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280-287, 1989
59. Parrillo J: Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993
60. Abel FL: Does the heart fail in endotoxin shock? Circ Shock 30:5-13, 1990
61. Hung J, Lew W: Temporal sequence of endotoxininduced systolic and diastolic myocardial depression in rabbits. Am J Physiol 265:H810-H819, 1993
62. Abel F: Myocardial function in sepsis and endotoxin shock. Am J Physiol 257:R1265-R1281, 1989
63. Natanson C, Eichenholz P, Danner R, et al: Endotoxin and tumor necrosis factor challenges in dogs stimulate the cardiovascular profile of human septic shock. J Exp Med 169:823-832, 1989
64. Pastor CM, Teisseire B, Vicaut E, et al: Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 22:465-469, 1994
65. Pastor CM, Payen D: Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 2:1-7, 1994
66. Payen D, Bernard C, Beloucif S: Nitric oxide in sepsis. Clin Chest Med 17:333-350, 1996
67. Ungureanu-Longrois D, Balligand J, Okada I, et al: Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ Res 77:486-493, 1995
68. Parrillo J: The cardiovascular pathophysiology of sepsis. Ann Rev Med 40:469-485, 1989
69. Finkel M, Oddis C, Jacob T, et al: Negative inotropic effect of cytokines on the heart mediated by nitric oxide. Science 257:387-389, 1992
70. Yokoyama T, Vaca L, Rossen RD, et al: Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 92:2303-2312, 1993
71. Oral H, Dorn GW, Mann DL: Sphingosin mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272: 4836, 1997
72. Balligand JL, Ungureanu D, Kelly RA, et al: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophageconditioned medium. J Clin Invest 91:2314-2319, 1993
73. Brady AJB, Poole-Wilson PA, Harding SE, et al: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263:H1963-H1966, 1992
74. Flesch M, Kilter H, Bohm M: Changes in cardiac signal transduction in septic shock. Vincent J (ed): Yearbook of Intensive Care and Emergency Medicine. Springer, BerlinHeidelberg, pp 45-56, 1996
75. Mebazaa A, Paqueron X, De Keulenaer GW, et al: Myocardial depression in endotoxemic rabbits is not due to the stimulation of nitric oxide (NO) release. Am J Respir Crit Care Med 153:A836, 1996(abstr)
76. Decking U, Flesche C, Godecke A, et al: Endotoxininduced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 268:H2460-H2465, 1995
77. Keller R, Jones J, Kim K, et al: Endotoxin-induced myocardial dysfunction: Is there a role for nitric oxide? Shock 4:338-344, 1995
78. Meng X, Ao L, Brown J, et al: Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 7:111-118, 1997
79. Brady AJB, Warren JB, Poole-Wilson PA, et al: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265:H176-H182, 1993
80. Kinugawa K, Kohmoto O, Yao A, et al: Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes. Am J Physiol 272:H35-H47, 1997
81. Schulz R, Smith J, Lewis M, et al: Nitric oxide synthesis in cultured endocardial cells of the pig. Br J Pharmacol 104:21-24, 1991
82. Xie Y, Shen W, Zhao G, et al: Role of endotheliumderived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro: Implications for the development of heart failure. Circ Res 79:381-387, 1996
83. Pinsky D, Cai B, Yang X, et al: The lethal effects of cytokine induced nitric oxide in cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor â. J Clin Invest 95:677-685, 1995